Cite

HARVARD Citation

    Gratacós, J. et al. (2007). Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate. Annals of the rheumatic diseases. 66 (4), pp. 493-497. [Online]. 
  
Back to record